510(k) Report

510(k) · Cleared

Cleared

L.a.M. Ipm Wound Gel, Ipm Derm Gel

K130781510(k) TraditionalCleared Feb 14, 2014330-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Glycobiosciences, Inc. · FRO Dressing, Wound, Drug

Cleared on Feb 14, 2014 as substantially equivalent to K962218 (Carrington Laboratories, Inc., 1996) and 4 other predicates after a 330-day review. Its family tree reaches back 6 generations to 1983. 1 of the 21 devices in its family, counting itself, has a Class I recall. 1 later device descends from it.

Decided
Feb 14, 2014
Review
330 days
Class
Class U
Product code
FRO
Recalls
None
Predicates
5

Its longest line of descent runs back 6 generations to K830708 (1983). 19 ancestors in all. 1 later device descends from it, 1 citing it directly. 1 of the 21 devices in this family, counting this one, has a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 2012: 1 other ancestor, 1 with a Class I recall12005: 1 other ancestor1996: 2 other ancestors2009: 1 other ancestor2003: 1 other ancestor1999: 1 other ancestor1997: 1 other ancestor1995: 2 other ancestors1994: 1 other ancestor1992: 1 other ancestor1990: 1 other ancestor2015: 1 descendant clearedK830708 · Duo Derm Flex Hydroactive Dressings & · Convatec, A Division of E.R. Squibb & Sons · 1983K984413 · Bionect Hydrogel · Fidia Pharmaceutical Corp. · 1999K020325 · L.a.M. Ipm Wound Gel · L.A.M. Pharmaceutical, Corp. · 2002K090725 · Oculus Microcyn Wound Gel · Oculus Innovative Sciences, Inc. · 2009K093585 · Microcyn Skin and Wound Hydrogel · Oculus Innovative Sciences, Inc. · 2010 · recalledK102945 · Pediacyn Atopic Dermatitis Hydrogel · Oculus Innovative Sciences, Inc. · 201119801990200020102020
  1. Root · 6 generations backK830708 Duo Derm Flex Hydroactive Dressings &Convatec, A Division of E.R. Squibb & Sons · 1983
  2. 5 generations backK984413 Bionect HydrogelFidia Pharmaceutical Corp. · 1999
  3. 4 generations backK020325 L.a.M. Ipm Wound GelL.A.M. Pharmaceutical, Corp. · 2002
  4. 3 generations backK090725 Oculus Microcyn Wound GelOculus Innovative Sciences, Inc. · 2009
  5. 2 generations backK093585 Microcyn Skin and Wound HydrogelOculus Innovative Sciences, Inc. · 2010 · Recalled
  6. 1 generation backK102945 Pediacyn Atopic Dermatitis HydrogelOculus Innovative Sciences, Inc. · 2011
  7. This deviceK130781 L.a.M. Ipm Wound Gel, Ipm Derm GelGlycobiosciences, Inc. · 2014
  8. Descendant · cites it directly · 0 of its ownK143527 IPM Wound Gel Bio, IPM Derm Gel BioGlycobiosciences, Inc. · 2015

Class I recalls in this family

Most influential descendants

Showing 1 of 1 · See all
  • K143527IPM Wound Gel Bio, IPM Derm Gel BioGlycobiosciences, Inc. · 2015 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K830708Duo Derm Flex Hydroactive Dressings &Convatec, A Division of E.R. Squibb & Sons1983—
−5K984413Bionect HydrogelFidia Pharmaceutical Corp.1999—
−4K020325L.a.M. Ipm Wound GelL.A.M. Pharmaceutical, Corp.2002—
−3K090725Oculus Microcyn Wound GelOculus Innovative Sciences, Inc.2009—
−2K093585Microcyn Skin and Wound HydrogelOculus Innovative Sciences, Inc.20101
−1K102945Pediacyn Atopic Dermatitis HydrogelOculus Innovative Sciences, Inc.2011—
0 (this device)K130781L.a.M. Ipm Wound Gel, Ipm Derm GelGlycobiosciences, Inc.2014—
+1K143527IPM Wound Gel Bio, IPM Derm Gel BioGlycobiosciences, Inc.2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
199210
199410
199520
199620
199710
199910
200310
200510
200910
201211

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201510
FIG. 1 — Lineage of K130781, 1983–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FRO device

  1. #1 K261023 Microdacyn Wound Irrigation Solutionscore 15.5 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K962218Carrasyn Hydrogel Wound Dressing,Carragauze Pads,Carragauze Strips,Carrasorb M FDG
Summary page 3
…roduct Classification Manufacturer Classification Number Name Code Name Panel K9622 18 Canrasyn MGQ Dressing, Wound Carrngton General & ilydrogel…
Carrington Laboratories, Inc.1996—
*K102945Pediacyn Atopic Dermatitis Hydrogel
Summary page 1
…ct code (classification): FRO Legally Marketed Predicate Devices: - Carrasyn Hydrogell Wound Dressing (K(962218); September 12, 1996 - Epicyn HydroGel (K102945); February 2, 2011 - MimyX Cream (K(041342); July 19, 2005 - L.A.M. 1PM Wound Gel (K(020325); April 15, 2002…
Oculus Innovative Sciences, Inc.2011—
*K041342Impruv a.I. Cream Wound and Skin Emulsion
Summary page 3
…Dressing, Wound, Oculus Innovative General & HydroGel Drug Sciences ic. Plastic Surgery K04 1342 MbnyX Cream MGQ Dressing. Wound Stiefel. General &…
Stiefel Laboratories, Inc.2005—
*K020325L.a.M. Ipm Wound Gel
Summary page 3
…tic Hydrogel W/Dr-ug Surgery and/or Biologic K020325 L.AM. 1PM MGQ Dressing, Wound LAM General & Wound Gel…
L.A.M. Pharmaceutical, Corp.2002—
*K123113L.a.M. Imp Wound Gel
Summary page 4
…use as its predicates; Epicyn HydroGel (K102945), Carrasyn Hydrogel Wound Dressing (K962218), MimyX Cream (K041342), LAM IPM Wound Gel (K020325) and L.AM 1PM Wound Gel (K123113)listed. Ad DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service…
Glycobiosciences, Inc.2012Class I

Also cleared against K962218: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K143527IPM Wound Gel Bio, IPM Derm Gel BioGlycobiosciences, Inc.20150

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K123113L.a.M. Imp Wound GelGlycobiosciences, Inc. · 2012 · Direct predicate · ◆ in the 2012 ancestors bar of FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 31 years and passes through 5 companies; a new generation was cleared every 3.2 years on median.
  • 2 of the 19 ancestors have a recall of any class; 1 has a Class I recall.
  • Of its descendants, K143527 (Glycobiosciences, Inc., 2015) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K962218.

How does its category compare?

All FRO devices

FRO Dressing, Wound, Drug: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · FRO

11in 2025

2007: 292008: 262009: 312010: 312011: 272012: 242013: 192014: 222015: 282016: 282017: 232018: 202019: 162020: 122021: 82022: 92023: 182024: 242025: 112026 (partial year): 17
2007high 31 (2009) · low 8 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FRO

176in 2025

2007: 187 days median2008: 130 days median2009: 136 days median2010: 146 days median2011: 177 days median2012: 96 days median2013: 194 days median2014: 214 days median2015: 249 days median2016: 222 days median2017: 147 days median2018: 206 days median2019: 270 days median2020: 226 days median2021: 275 days median2022: 332 days median2023: 283 days median2024: 263 days median2025: 176 days median2026 (partial year): 254 days median
2007high 332 (2022) · low 96 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FRO

2in 2024

2007: 42008: 12009: 12011: 42013: 12014: 12015: 22016: 32017: 12019: 12021: 62022: 22023: 2, 2 Class I2024: 22026 (partial year): 2
2007high 6 (2021) · low 0 (2010)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · FRO

192in 2025

2007: 552008: 302009: 452010: 1222011: 422012: 652013: 1392014: 2692015: 2972016: 1472017: 1492018: 1282019: 1362020: 1392021: 1832022: 1762023: 1982024: 2322025: 192
2007high 297 (2015) · low 30 (2008)2025

MAUDE reports naming product code FRO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200729187455
200826130130
200931136145
2010311460122
201127177442
20122496065
2013191941139
2014222141269
2015282492297
2016282223147
2017231471149
2018202060128
2019162701136
2020122260139
202182756183
202293322176
2023182832 (2)198
2024242632232
2025111760192
2026172542—

What is it indicated for?

L.A.M. 1PM Wound Gel/IPM Derm Gel is indicated for management of minor burns (1st degree burns), minor abrasions, minor cuts and helps to relieve dry waxy skin irritations associated with dry skin conditions. Under the supervision of a health care professional; L.A.M. 1PM Wound Gel/IPM Derm Gel is indicated for management of exudating wounds such as leg ulcers, pressure ulcers, diabetic ulcers, surgical wounds (post-operative incisions and donor sites)…

Read the full statement (111 words)

L.A.M. 1PM Wound Gel/IPM Derm Gel is indicated for management of minor burns (1st degree burns), minor abrasions, minor cuts and helps to relieve dry waxy skin irritations associated with dry skin conditions.

Under the supervision of a health care professional;

L.A.M. 1PM Wound Gel/IPM Derm Gel is indicated for management of exudating wounds such as leg ulcers, pressure ulcers, diabetic ulcers, surgical wounds (post-operative incisions and donor sites), mechanically or surgically debrided wounds, and for second degree burns.

L.A.M. 1PM Wound Gel/IPM Derm Gel is indicated for the management and relief of burning, itching and pain associated with various types of dermatoses; including atopic dermatitis, allergic contact dermatitis and radio-dermatitis.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K130781: L.a.M. Ipm Wound Gel, Ipm Derm Gel.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K130781

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026